The role of CASPR2 in regulating sensory neuronal excitability and chronic pain

CASPR2在调节感觉神经元兴奋性和慢性疼痛中的作用

基本信息

  • 批准号:
    MR/M02394X/1
  • 负责人:
  • 金额:
    $ 44.02万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2015
  • 资助国家:
    英国
  • 起止时间:
    2015 至 无数据
  • 项目状态:
    已结题

项目摘要

Pain alerts the body to actual or potential tissue damage and thereby helps to prevent any initial or further injury. In the case where tissue is damaged the sensation of pain is enhanced in an effort to protect the injured area and speed the recovery process. Therefore pain is a useful sensation albeit an unpleasant one. However pain can become maladaptive, persisting beyond its usefulness and becoming debilitating for the sufferer. This type of pain, which persists for months and in some cases years, is termed chronic pain and affects 1 in 5 adults. It has major economic repercussions due to treatment costs and time spent off work and this is in spite of current analgesic use. In addition to a lack of efficacy current analgesics also cause severe side-effects. We have new data to suggest that contactin associated protein 2 (CASPR2), a protein expressed within the sensory nervous system, can regulate pain sensibility. Autoantibodies to this protein have recently been associated with neuropathic pain in patients. The main aim of this project will be to determine the role of CASPR2 in both acute and chronic pain states. We will develop an animal model in order to understand how CASPR2 autoantibodies cause chronic pain. Furthermore levels of CASPR2 fall after nerve injury. We will determine if this contributes to neuropathic pain through its known interactions with potassium channels which have an important role in regulating neuronal excitability. Our aim is to define how CASPR2 alters function within the sensory nervous system to better target current therapeutics in patients with autoantibodies to this protein but also to potentially develop novel therapeutics for the treatment of neuropathic pain.
疼痛提醒身体注意实际或潜在的组织损伤,从而有助于防止任何初始或进一步的损伤。在组织受损的情况下,疼痛的感觉会增强,以保护受伤部位并加速恢复过程。因此,疼痛是一种有用的感觉,尽管是一种不愉快的感觉。然而,疼痛可能变得适应不良,持续超过其有用性,并成为患者衰弱。这种类型的疼痛持续数月,在某些情况下持续数年,被称为慢性疼痛,影响五分之一的成年人。由于治疗费用和下班时间,它具有重大的经济影响,尽管目前使用止痛药。除了缺乏功效之外,目前的镇痛剂还引起严重的副作用。我们有新的数据表明,接触相关蛋白2(CASPR2),一种在感觉神经系统内表达的蛋白质,可以调节疼痛敏感性。这种蛋白质的自身抗体最近与患者的神经性疼痛有关。该项目的主要目的是确定CASPR2在急性和慢性疼痛状态中的作用。我们将开发一种动物模型,以了解CASPR2自身抗体如何引起慢性疼痛。此外,CASPR2水平在神经损伤后下降。我们将确定这是否有助于神经性疼痛,通过其已知的相互作用与钾通道,在调节神经元兴奋性的重要作用。我们的目标是确定CASPR2如何改变感觉神经系统内的功能,以更好地靶向具有该蛋白自身抗体的患者的当前治疗方法,同时也可能开发用于治疗神经性疼痛的新型治疗方法。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability
免疫或遗传介导的 CASPR2 破坏会因初级传入兴奋性增强而导致疼痛过敏
  • DOI:
    10.5167/uzh-150090
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Dawes, John M
  • 通讯作者:
    Dawes, John M
Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero.
  • DOI:
    10.1007/s00401-017-1751-5
  • 发表时间:
    2017-10
  • 期刊:
  • 影响因子:
    12.7
  • 作者:
    Coutinho E;Menassa DA;Jacobson L;West SJ;Domingos J;Moloney TC;Lang B;Harrison PJ;Bennett DLH;Bannerman D;Vincent A
  • 通讯作者:
    Vincent A
Leucine-Rich Glioma-Inactivated 1 versus Contactin-Associated Protein-like 2 Antibody Neuropathic Pain: Clinical and Biological Comparisons.
  • DOI:
    10.1002/ana.26189
  • 发表时间:
    2021-10
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Ramanathan S;Tseng M;Davies AJ;Uy CE;Paneva S;Mgbachi VC;Michael S;Varley JA;Binks S;Themistocleous AC;Fehmi J;Anziska Y;Soni A;Hofer M;Waters P;Brilot F;Dale RC;Dawes J;Rinaldi S;Bennett DL;Irani SR
  • 通讯作者:
    Irani SR
Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability.
  • DOI:
    10.1016/j.neuron.2018.01.033
  • 发表时间:
    2018-02-21
  • 期刊:
  • 影响因子:
    16.2
  • 作者:
    Dawes JM;Weir GA;Middleton SJ;Patel R;Chisholm KI;Pettingill P;Peck LJ;Sheridan J;Shakir A;Jacobson L;Gutierrez-Mecinas M;Galino J;Walcher J;Kühnemund J;Kuehn H;Sanna MD;Lang B;Clark AJ;Themistocleous AC;Iwagaki N;West SJ;Werynska K;Carroll L;Trendafilova T;Menassa DA;Giannoccaro MP;Coutinho E;Cervellini I;Tewari D;Buckley C;Leite MI;Wildner H;Zeilhofer HU;Peles E;Todd AJ;McMahon SB;Dickenson AH;Lewin GR;Vincent A;Bennett DL
  • 通讯作者:
    Bennett DL
Autism Spectrum Disorders: Multiple Routes to, and Multiple Consequences of, Abnormal Synaptic Function and Connectivity.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Bennett其他文献

Detailed assessment of cognition and activities of daily living in moderate to severe Alzheimer's disease
详细评估中度至重度阿尔茨海默病的认知和日常生活活动
  • DOI:
    10.1016/s0197-4580(00)82096-5
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    D. Galasko;F. Schmitt;Shelia Jin;J. Saxton;David Bennett;M. Sano;S. Ferris
  • 通讯作者:
    S. Ferris
The MOA Project 2013 Observing Season
MOA项目2013年观测季
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    David Bennett;MOA Collaboration
  • 通讯作者:
    MOA Collaboration
Specific alterations of tau phosphorylation and neuronal signaling induced by the amyloid-β oligomer Aβ*56
  • DOI:
    10.1016/j.neurobiolaging.2016.01.117
  • 发表时间:
    2016-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sylvain Lesne;Fatou Amar;Mathew Sherman;Travis Rush;Megan Larson;Liu Chang;Jürgen Götz;Julie Schneider;David Bennett;Karen Ashe;Alain Buisson
  • 通讯作者:
    Alain Buisson
Kiosk 5R-TC-07 - Repeatability and Reliability of Flow Quantification in Aorta and Abdominal Arteries by 2D PC-MRI
5R-TC-07 自助服务终端 - 二维 PC-MRI 对主动脉和腹主动脉血流定量的重复性和可靠性
  • DOI:
    10.1016/j.jocmr.2024.100702
  • 发表时间:
    2024-03-01
  • 期刊:
  • 影响因子:
    6.100
  • 作者:
    Preethi Chandrasekaran;Juliet Varghese;Harmony Nguyen;Jianing Ma;Jing Peng;Rohit Sood;Paul Wilkens;David Bennett;Orlando Simonetti;Matthew Tong
  • 通讯作者:
    Matthew Tong
Translational research into causes of neuropathic pain
  • DOI:
    10.1016/j.jns.2023.120989
  • 发表时间:
    2023-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    David Bennett
  • 通讯作者:
    David Bennett

David Bennett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Bennett', 18)}}的其他基金

MICA: Partnership for Assessment and Investigation of Neuropathic Pain: Studies Tracking Outcomes, Risks and Mechanisms (PAINSTORM).
MICA:神经病理性疼痛评估和调查伙伴关系:跟踪结果、风险和机制的研究 (PAINSTORM)。
  • 批准号:
    MR/W002388/1
  • 财政年份:
    2021
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Research Grant
Defining the primary afferent circuitry that drives neuropathic pain
定义驱动神经性疼痛的主要传入回路
  • 批准号:
    MR/T020113/1
  • 财政年份:
    2020
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Research Grant
Using human IPSC derived nociceptors as a cellular model to investigate and therapeutically target Nav1.7
使用人类 IPSC 衍生的伤害感受器作为细胞模型来研究和治疗靶向 Nav1.7
  • 批准号:
    BB/S006788/1
  • 财政年份:
    2019
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Research Grant
Cold and Possibly Unbound Planets from Wide-Field Microlensing Surveys
广域微透镜勘测中的寒冷且可能未束缚的行星
  • 批准号:
    1211875
  • 财政年份:
    2012
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
CNH: People, Water, and Climate: Adaptation and Resilience in Agricultural Watersheds
CNH:人、水和气候:农业流域的适应和恢复力
  • 批准号:
    1114978
  • 财政年份:
    2011
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
Next Generation Microlensing Planet Search Analysis and Observations
下一代微透镜行星搜索分析和观测
  • 批准号:
    1009621
  • 财政年份:
    2010
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
Analysis and Interpretation of Planetary Gravitational Microlensing Events
行星引力微透镜事件的分析和解释
  • 批准号:
    0708890
  • 财政年份:
    2007
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
HSD: Collaborative Research: Social Complexity and the Management of the Commons
HSD:合作研究:社会复杂性和公地管理
  • 批准号:
    0624297
  • 财政年份:
    2006
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Standard Grant
Observations and Analysis of Exotic Gravitational Microlensing Events
奇异引力微透镜事件的观测与分析
  • 批准号:
    0206189
  • 财政年份:
    2002
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Continuing Grant
A Search for Extra-Solar Planets via Gravitational Microlensing
通过引力微透镜寻找太阳系外行星
  • 批准号:
    9619575
  • 财政年份:
    1997
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Continuing Grant

相似国自然基金

自闭症相关受体CASPR2功能失调和药理学干预的机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
接触蛋白相关蛋白2(Caspr2)自身抗体在神经系统产生免疫损伤的机制研究
  • 批准号:
    2018JJ3806
  • 批准年份:
    2018
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目

相似海外基金

The role of CASPR2 in central oxytocin system development
CASPR2在中枢催产素系统发育中的作用
  • 批准号:
    RGPIN-2021-03732
  • 财政年份:
    2022
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Discovery Grants Program - Individual
The role of CASPR2 in central oxytocin system development
CASPR2在中枢催产素系统发育中的作用
  • 批准号:
    RGPIN-2021-03732
  • 财政年份:
    2021
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Discovery Grants Program - Individual
The role of CASPR2 in central oxytocin system development
CASPR2在中枢催产素系统发育中的作用
  • 批准号:
    DGECR-2021-00484
  • 财政年份:
    2021
  • 资助金额:
    $ 44.02万
  • 项目类别:
    Discovery Launch Supplement
A diagnostic for maternal autoAb to Caspr2 to predict increased risk of autism spectrum disorder in children
Caspr2 母体自身抗体的诊断可预测儿童自闭症谱系障碍的风险增加
  • 批准号:
    9344768
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Developing a prenatal biologic therapy to mitigate ASD risk from maternal autoantibodies to Caspr2
开发产前生物疗法以降低母亲 Caspr2 自身抗体导致的 ASD 风险
  • 批准号:
    9762135
  • 财政年份:
    2017
  • 资助金额:
    $ 44.02万
  • 项目类别:
Mechanisms of Caspr2 antibodies
Caspr2抗体的机制
  • 批准号:
    8539645
  • 财政年份:
    2012
  • 资助金额:
    $ 44.02万
  • 项目类别:
Mechanisms of Caspr2 antibodies
Caspr2抗体的作用机制
  • 批准号:
    8383911
  • 财政年份:
    2012
  • 资助金额:
    $ 44.02万
  • 项目类别:
Mechanisms of Caspr2 antibodies
Caspr2抗体的机制
  • 批准号:
    9109066
  • 财政年份:
    2012
  • 资助金额:
    $ 44.02万
  • 项目类别:
Caspr2 as an autism candidate gene: a proteomic approach to function & structure.
Caspr2 作为自闭症候选基因:功能的蛋白质组学方法
  • 批准号:
    8849503
  • 财政年份:
    2011
  • 资助金额:
    $ 44.02万
  • 项目类别:
CELLULAR CHARACTERIZATION OF CASPR2
CASPR2 的细胞特征
  • 批准号:
    8361928
  • 财政年份:
    2011
  • 资助金额:
    $ 44.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了